Context before conclusions.
A symptom or lab value is one part of a larger picture. Your history, life stage, and priorities belong in the conversation.
Morrow / Our approach
You bring your story. Care should listen.
A connected approach to women’s health: thoughtful questions, useful information, and clinical decisions that consider the whole person.
The care journey
Thoughtful care.
A clear next step.
- 1
Tell us where you’d like to begin.
Start with your questions, priorities, and the changes you want to understand.
- 2
Build your clinical picture.
A clinical evaluation—and testing when appropriate—helps put your health in context.
- 3
Make a plan with your clinician.
Discuss the findings, available options, and an individualized path forward.
Options, not assumptions.
Testing and medication are considered when appropriate—not treated as the inevitable next step.
Clarity at every step.
Understand what is being considered, why it matters, and which questions to ask before making a decision.
Good questions.
Clear answers.
Do I need bloodwork before treatment?
Not always. A licensed clinician considers your history, symptoms, medications, and goals before deciding whether testing is useful. The tests and timing should answer a specific clinical question.
What does 503A mean?
Section 503A of the Federal Food, Drug, and Cosmetic Act describes conditions for certain compounded drugs, including a valid prescription for an identified individual patient. Compounding may be considered when an FDA-approved medication cannot meet a particular patient’s medical needs.
Are compounded medications FDA-approved?
No. Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before marketing. Compounding carries risks, including contamination and incorrect strength. Ask your clinician about approved alternatives and the risks and benefits for you.
A little clarity changes the conversation.